ESC Premium Access

PP1 activation as novel antiarrhythmic approach in human heart failure

Topic: Excitation-contraction coupling and contractile remodelling

Presentation

About the speaker

Doctor Joerg Eiringhaus

Hannover Medical School, Hannover (Germany)
0 follower

6 more presentations in this session

Characterization of a novel genetic variant associated with Brugada syndrome: beta-2-syntrophin mutation impairs interaction with SCN5A and reduces Na+ current in human cardiomyocytes

Speaker: Doctor C. Schmidt (Heidelberg, DE)

Thumbnail

A mutation in the gene encoding the tbx5 transcription factor is associated with the Brugada Syndrome

Speaker: Professor R. Caballero (Madrid, ES)

Thumbnail

Optogenetic cardioversion terminates atrial fibrillation in wild-type mice after gene transfer

Speaker: Doctor T. Beiert (Bonn, DE)

Thumbnail

Local epicardial light pulse terminates ventricular arrhythmias in the adult rat heart upon optogenetic modification: towards biological shockless defibrillation.

Speaker: Mr E. Nyns (Leiden, NL)

Thumbnail

Patient-specific iPSC-derived cardiomyocytes reveal a disease-causing role of an ACTN2 mutation in HCM and an unexpected LQT phenotype

Speaker: Doctor M. Lemoine (Hamburg, DE)

Thumbnail

Access the full session

Cellular and molecular electrophysiology

Speakers: Doctor J. Eiringhaus, Doctor C. Schmidt, Professor R. Caballero, Doctor T. Beiert, Mr E. Nyns...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk